We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$296M
2
SMCI icon
Super Micro Computer
SMCI
+$134M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M
4
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$76.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$58.2M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMG
5901
Nouveau Monde Graphite
NMG
$454M
– –
-1
Closed -$2
NPFD icon
5902
Nuveen Variable Rate Preferred & Income Fund
NPFD
$446M
– –
-263
Closed -$4.98K
NRXP icon
5903
NRX Pharmaceuticals
NRXP
$153M
– –
-2,544
Closed -$4.3K
NUDV icon
5904
Nuveen ESG Dividend ETF
NUDV
$51.1M
– –
-22,327
Closed -$662K
NUTX
5905
Nutex Health
NUTX
$1.11B
– –
-281
Closed -$6.1K
NVCT icon
5906
Nuvectis Pharma
NVCT
$617M
– –
-588
Closed -$3.7K
NVDQ icon
5907
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$13.8M
– –
-24
Closed -$2.26K
NXL icon
5908
Nexalin Technology
NXL
$7.77M
– –
-6,573
Closed -$4.4K
NYAX
5909
Nayax
NYAX
$2.58B
– –
-36
Closed -$908
NYC
5910
American Strategic Investment Co
NYC
$27.6M
– –
-429
Closed -$3.96K
OBE
5911
Obsidian Energy
OBE
$662M
– –
-351
Closed -$1.95K
OCSL icon
5912
Oaktree Specialty Lending
OCSL
$1.14B
– –
-6,637
Closed -$108K
OM icon
5913
Outset Medical
OM
$90.8M
– –
-568
Closed -$5.77K
ONCY
5914
Oncolytics Biotech
ONCY
$95.8M
– –
-2,017
Closed -$1.78K
OTLY
5915
Oatly Group
OTLY
$438M
– –
-294
Closed -$5.02K
OUSA icon
5916
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$762M
– –
-5,195
Closed -$281K
OUSM icon
5917
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$885M
– –
-9,549
Closed -$430K
PBHC icon
5918
Pathfinder Bancorp
PBHC
$104M
– –
-257
Closed -$4.07K
PBUS icon
5919
Invesco MSCI USA ETF
PBUS
$11.8B
– –
-1,414
Closed -$81.2K
PDT
5920
John Hancock Premium Dividend Fund
PDT
$626M
– –
-488
Closed -$6.45K
PET
5921
DELISTED
Wag!
PET
– –
-5,420
Closed -$4.66K
PFX icon
5922
PhenixFIN
PFX
$90M
– –
-292
Closed -$13.9K
IFLN
5923
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
– –
-2
Closed -$37
PHUN icon
5924
Phunware
PHUN
$43.6M
– –
-2,242
Closed -$7.67K
PICK icon
5925
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.33B
– –
-45
Closed -$1.94K
235 236
237
238 239

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.